4O0B | Identification of novel HSP90/isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease | date | |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
authors | Zuccola, H.J., Ernst, J.T. | ||||||||||||||
compound | source | ||||||||||||||
symmetry |
| ||||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 1.93 | ||||||||||||
ligand | 2QA | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Identification of novel HSP90alpha/beta isoform selective inhibitors using structure-based drug design. Demonstration of potential utility in treating CNS disorders such as Huntington's disease., Ernst J, Neubert T, Liu M, Sperry S, Zuccola H, Turnbull A, Fleck B, Kargo W, Woody L, Chiang P, Tran D, Chen W, Snyder PW, Alcacio T, Nezami A, Reynolds J, Alvi K, Goulet L, Stamos D, J Med Chem. 2014 Mar 27. PMID:24673104 |
Data retrieval |
View 4O0B in 3D |
Visual 3D analysis of 4O0B |
Structure-derived information |
Sequence-derived information |
Other resources with information on 4O0B |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |